Stryker, a leading medical technology company, marketed its Rejuvenate system as the next generation and latest evolution in hip replacement products. The complex design was intended to offer greater stability and minimal bone stress, and was marketed to younger patients because of its durability and range of motion.
The product hit the market in 2009 after little testing on safety and effectiveness of the device prior to the launch. In April 2012, Stryker issued an Urgent Safety Alert to surgeons, which listed a number of safety risks to patients. A month later, Stryker recalled the Rejuvenate Modular due to “fretting and/or corrosion” in the implant that may lead to “adverse local tissue reaction” and possible pain and/or swelling.
Although the company willingly recalled its product, it has not accepted full legal responsibility for the alleged defects and failure of the device. Patients throughout the US have suffered from metallosis (build-up of metal debris in soft tissue) and tissue damage, and have had to undergo a painful and complicated revision surgery to remove and replace the faulty Rejuvenate implant. Lawsuits filed against Stryker have charged the product as defective and dangerous because it is prone to fretting, degradation and fracture. Also, the suits state that Stryker knew or should have been aware that its hip systems were not fit for market, but continued to sell them.
If you’ve received a Stryker Rejuvenate hip or other faulty medical equipment, call 843-720-2800 and get The Firm behind you.